ERS | monograph Preface John Hurst Asthma is the most common chronic respiratory disease and of wide relevance to the majority of respiratory clinicians. Despite considerable research activity and clinical experience, the challenge of severe asthma remains defined broadly as asthma that responds poorly to currently available medications. It is now 8 years since the ERS Monograph on Difficult-to-Treat Asthma and it has rightly proved one of our most popular editions. With the rapid pace of change in the field, it was clear that the edition needed updating and thus it is a pleasure to introduce this completely new Monograph on Severe Asthma. The Guest Editors, Professors Fan Chung, Elliot Israel and Peter G. Gibson have produced an excellent book that provides a state-of-the-art summary of the field, bringing the latest research findings through to clinical practice and including the patient voice. I thank them for their considerable work. Addressing topics from definitions, mechanisms and patho- physiology, through to clinical phenotypes and management, there is truly something here to interest everyone. The authors consider both paediatric and adult disease, with example case histories. I have no doubt that this issue will be popular and well-read, and I unreservedly recommend it to all those with a clinical and/or research interest in severe asthma as a new “go to” reference work on the topic. Disclosures: John R. Hurst reports receiving grants, personal fees and non- financial support from pharmaceutical companies that make medicines to treat respiratory disease. This includes reimbursement for educational activities and advisory work, and support to attend meetings. Copyright ©ERS 2019. Print ISBN: 978-1-84984-103-0. Online ISBN: 978-1-84984-104-7. Print ISSN: 2312-508X. Online ISSN: 2312-5098. v
Previous Page Next Page